Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of Breast Cancer Risk Evaluation in Women From the General Population

NCT02997384 is registered in ClinicalTrials.gov with Gustave Roussy, Cancer Campus, Grand Paris as lead sponsor.

NCT NCT02997384
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02997384 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of Breast Cancer Risk Evaluation in Women From the General Population
Lead sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Phase
Observational
Overall status
Unknown status
Start date
December 31, 2016
Completion date
June 30, 2018
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breastcancer